Cargando…
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
INTRODUCTION: Immune checkpoint inhibitors (ICI) have been approved for patients with clear cell renal cell carcinoma (ccRCC), but not all patients benefit from ICI. One reason is the tumor microenvironment (TME) that has substantial influence on patient's prognosis and therapy response. Thus,...
Autores principales: | Stenzel, Philipp J., Schindeldecker, Mario, Tagscherer, Katrin E., Foersch, Sebastian, Herpel, Esther, Hohenfellner, Markus, Hatiboglu, Gencay, Alt, Juergen, Thomas, Christian, Haferkamp, Axel, Roth, Wilfried, Macher-Goeppinger, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031108/ https://www.ncbi.nlm.nih.gov/pubmed/31881506 http://dx.doi.org/10.1016/j.tranon.2019.11.002 |
Ejemplares similares
-
Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma
por: Radspieler, Melissa Marie, et al.
Publicado: (2019) -
Expression and Functional Characterization of the BNIP3 Protein in Renal Cell Carcinomas
por: Macher-Goeppinger, Stephan, et al.
Publicado: (2017) -
Prognostic relevance of androgen receptor expression in renal cell carcinomas
por: Foersch, Sebastian, et al.
Publicado: (2017) -
Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell Carcinoma
por: Stenzel, Philipp J., et al.
Publicado: (2021) -
MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker
por: Macher-Goeppinger, Stephan, et al.
Publicado: (2016)